Back to Journals » Lung Cancer: Targets and Therapy » Volume 10
Review
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Profile of entrectinib and its potential in the treatment of ROS1-positive NSCLC: evidence to date
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
10,997 | Dovepress* | 6,822+ | 1,275 | 8,097 | |
PubMed Central* | 4,175 | 670 | 4,845 | ||
Totals | 10,997 | 1,945 | 12,942 | ||
*Since 9 September 2019 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
2 | 0 | 0 | 1 | 0 | 1 |
View citations on PubMed Central and Google Scholar